Form 4: BDX Director Acquires Shares in Deferred Comp Plan

Becton Dickinson Director Christopher Jones acquired 272 derivative securities through a deferred compensation plan.

Summary

• Christopher Ian Montague Jones, a Director at Becton Dickinson & Co (BDX), acquired 272 derivative securities.
• The acquisition occurred on February 4, 2026, as part of the BD Deferred Compensation Plan.
• These securities convert to common stock on a one-for-one basis.
• The price of the derivative securities was $201.91 per unit.
• Following this transaction, Mr. Jones beneficially owns 11,649 derivative securities.
• The reported amount includes rights acquired through dividend reinvestment since the last report.
• Securities are distributed upon termination of service as a director or on specified dates.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, as it represents a director's continued accumulation of company equity, albeit through a compensation plan, reinforcing alignment with shareholder interests.

Positives

• A director's acquisition of shares, even through a deferred compensation plan, can signal continued alignment of interests with shareholders.
• The inclusion of dividend reinvestment indicates a long-term holding strategy for these deferred compensation units.

Future Outlook

The filing indicates that the acquired securities will be distributed following the termination of the reporting person's service as a director or on specific dates chosen by the reporting person, suggesting a long-term holding and vesting structure.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition by a director, are routinely reported in the healthcare equipment and supplies industry. While this specific transaction is part of a compensation plan, it reflects ongoing executive participation in the company's equity structure, which is a common practice across the sector.

Comparison to Industry Standards

• Director participation in deferred compensation plans that include equity components is a standard practice in large-cap healthcare companies, aligning executive incentives with long-term shareholder value.
• The one-for-one conversion of derivative securities to common stock is a typical structure for such plans, similar to those seen at peers like Medtronic (MDT) or Johnson & Johnson (JNJ) for their executive compensation schemes.

Stakeholder Impact

• Shareholders: The transaction indicates continued director ownership and alignment with shareholder interests through equity participation.
• Employees: No direct impact on general employees is noted.

Next Steps

• The securities will be distributed following the termination of Christopher Jones' service as a director or on dates specified by him.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction related to a deferred compensation plan. It does not contain information that would fundamentally alter the investment thesis for Becton Dickinson & Co. While director ownership is generally positive, this specific transaction is not significant enough to warrant a change in recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Becton Dickinson, BDX, Form 4, Insider Transaction, Director Stock Acquisition, Deferred Compensation, Equity Ownership